SMN1 and Duchenne muscular dystrophy: Based on this mechanism, gene therapy methods for a variety of disorders, such as Duchenne muscular dystrophy (DMD) [82,83,84,85,86,87], β-thalassemia [88], SMA [89], Pompe disease [90], and others, have been examined (Table 3).